Differences in direction-dependent shortening of the left ventricular wall in hypertrophic cardiomyopathy and in

Related Experiment Video

Updated: Aug 11, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

M Hattori1, T Aoki, K Sekioka

  • 1First Department of Internal Medicine, Mie University, Japan.

The American Journal of Cardiology
|November 15, 1992
PubMed

Insights

Patients with hypertrophic cardiomyopathy (HC) show abnormal left ventricular (LV) wall contraction, with reduced meridional shortening. This direction-dependent contraction pattern helps distinguish HC from hypertension using echocardiography.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HC) is characterized by myocardial abnormalities.
  • Left ventricular (LV) wall motion alterations may indicate underlying pathology.
  • Distinguishing HC from other cardiac conditions like hypertension is clinically important.

Purpose of the Study:

  • To investigate if patients with HC exhibit altered left ventricular (LV) wall contraction modes.
  • To correlate geometric changes in the LV wall with myocardial abnormalities in HC.
  • To identify echocardiographic markers for differentiating HC from essential systemic hypertension.

Main Methods:

  • Two-dimensional echocardiography was used to analyze LV wall geometry at end-diastole and end-systole.
  • Meridional and circumferential shortening, and mean wall thickening were measured.
  • Data from 18 nonobstructive HC patients were compared to 31 normal subjects and 19 hypertensive patients.

Main Results:

  • Normal subjects and hypertensive patients showed similar meridional and circumferential shortening, with increased LV cross-sectional area at end-systole.
  • HC patients demonstrated significantly reduced meridional shortening and mean wall thickening (p < 0.001 and p < 0.01, respectively).
  • A striking difference between meridional and circumferential shortening was observed in HC patients (p < 0.001), with no increase in LV cross-sectional area at end-systole.

Conclusions:

  • Patients with HC exhibit direction-dependent LV wall contraction, characterized by impaired meridional shortening.
  • Echocardiographic assessment of contraction patterns can differentiate HC from essential systemic hypertension.
  • Altered LV wall mechanics in HC are linked to underlying myocardial abnormalities.

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...